Canada Drug Testing Market Size & Outlook, 2025-2030
Related Markets
Canada drug testing market highlights
- The Canada drug testing market generated a revenue of USD 354.9 million in 2024 and is expected to reach USD 464.8 million by 2030.
- The Canada market is expected to grow at a CAGR of 4.6% from 2025 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2024.
- Rapid Testing Devices is the most lucrative product segment registering the fastest growth during the forecast period.
Drug testing market data book summary
| Market revenue in 2024 | USD 354.9 million |
| Market revenue in 2030 | USD 464.8 million |
| Growth rate | 4.6% (CAGR from 2024 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Rapid Testing Devices |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Consumables, Instruments, Rapid Testing Devices, Services |
| Key market players worldwide | Quest Diagnostics Inc, Abbott Laboratories, QuidelOrtho Corp, Roche Holding AG ADR, Thermo Fisher Scientific Inc, Siemens Healthineers AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Labcorp Holdings Inc, Clinical Reference Laboratory, Cordant Health Solutions, Legacy Medical, Draegerwerk AG & Co KGaA, Omega Laboratories |
Other key industry trends
- In terms of revenue, Canada accounted for 2.6% of the global drug testing market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. drug testing market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 8,598.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Drug Testing Market Scope
Drug Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Omega Laboratories | View profile | 101-250 | Mogadore, Ohio, United States, North America | https://www.omegalaboratories.com/ |
| Legacy Medical | View profile | 11-50 | Bismarck, North Dakota, United States, North America | https://legacymedical.com |
| Cordant Health Solutions | View profile | 501-1000 | Flagstaff, Arizona, United States, North America | https://cordantsolutions.com |
| Clinical Reference Laboratory | View profile | 501-1000 | Lenexa, Kansas, United States, North America | https://www.crlcorp.com |
| Draegerwerk AG & Co KGaA | View profile | 16476 | Moislinger Allee 53–55, Lubeck, Germany, 23542 | https://www.draeger.com |
| Labcorp Holdings Inc | View profile | 67000 | 358 South Main Street, Burlington, NC, United States, 27215 | https://www.labcorp.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| QuidelOrtho Corp | View profile | 7100 | 9975 Summers Ridge Road, San Diego, CA, United States, 92121 | https://www.quidelortho.com |
| Quest Diagnostics Inc | View profile | 48000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | https://www.questdiagnostics.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Siemens Healthineers AG ADR | View profile | 71400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | https://www.siemens-healthineers.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Canada drug testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug testing market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 35.81% in 2024. Horizon Databook has segmented the Canada drug testing market based on consumables, instruments, rapid testing devices, services covering the revenue growth of each sub-segment from 2018 to 2030.
The market also reflects a shift toward portable and rapid testing solutions, allowing for onsite testing and quick results. In Canada, drug testing is governed by federal and provincial regulations, ensuring a balance between workplace safety and individual privacy rights.
Moreover, employers are adopting comprehensive testing programs to ensure a safe working environment. In addition, increasing number of industry developments such as joint ventures, collaborations, and acquisitions is projected to have a positive impact on the market.
For instance, in March 2023, SOBR Safe, Inc., one of the leading providers of alcohol detection solutions, signed a strategic collaboration with Alco Prevention Canada (Alco) to consolidate its presence in Canada.
Reasons to subscribe to Canada drug testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada drug testing market databook
-
Our clientele includes a mix of drug testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada drug testing market , including forecasts for subscribers. This country databook contains high-level insights into Canada drug testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada Product - Drug Testing Market size, 2024 - 2030 (US$M)
Canada Drug Testing Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
